Voraxaze Європейський Союз - польська - EMA (European Medicines Agency)

voraxaze

serb sas - glucarpidase - metabolic side effects of drugs and substances - wszystkie inne produkty terapeutyczne - voraxaze is indicated to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity.

Dimethyl fumarate Neuraxpharm Європейський Союз - польська - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - fumaran dimetylu - stwardnienie rozsiane, Рецидивно-znika - leki immunosupresyjne - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Orgovyx Європейський Союз - польська - EMA (European Medicines Agency)

orgovyx

accord healthcare s.l.u. - relugolix - nowotwory stercza - terapia endokrynologiczna - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.